Get the Stockscreener App
7.28
2.16%
0.32
Aligos Therapeutics Inc Stock (ALGS) Forecast
The Aligos Therapeutics Inc (ALGS) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $6.2266, representing a -14.47% decrease from the current price of $7.28. The highest analyst price target is $6.2607, and the lowest is $6.1924.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ALGS Price Target
Average 4.7882
(-34.23% Downside)
Is Aligos Therapeutics Inc (ALGS) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 49.77 | Neutral |
| STOCH(9,6) | 21.52 | Neutral |
| STOCHRSI(14) | 49.76 | Neutral |
| MACD(12,26) | -0.106 | Buy |
| ADX(14) | 9.2504 | Neutral |
| William %R | -59.68 | Neutral |
| CCI(14) | -30.67 | Neutral |
Buy: 1
Sell: 0
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
7.1495
Buy
|
7.0705
Buy
|
| MA20 |
7.0973
Buy
|
7.1284
Buy
|
| MA50 |
7.3816
Sell
|
7.531
Sell
|
| MA100 |
8.2991
Sell
|
8.1496
Sell
|
| MA200 |
8.69
Sell
|
10.05
Sell
|
Buy: 4
Sell: 6
Neutral: 0
Summary: Sell
According to our latest analysis, ALGS could be considered a Neutral, with 17 technical analysis indicators signaling 5 Buy signals, 6 signaling Sell signals and 6 Neutral signals. This suggests that investors should exercise caution when entering new positions on ALGS, as the market is likely to remain volatile in the near term.
- RSI (Relative Strength Index): The RSI(14) value of 49.77 indicates that ALGS is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 21.52 indicates that ALGS is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 49.76 indicates that ALGS is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 9.2504 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -30.67 indicates that ALGS is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term ALGS price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Aligos Therapeutics Inc financial reports and earnings history, Aligos Therapeutics Inc (ALGS) stock could reach $15.55 by 2030, $6.0233 by 2040 and $56.37 by 2050. See the projected annual prices until 2050 of the Aligos Therapeutics Inc stock below:
- Aligos Therapeutics Inc (ALGS) is expected to reach an average price of $13.57 in 2035, with a high prediction of $13.76 and a low estimate of $13.63. This indicates an $86.46% rise from the last recorded price of $7.28.
- Aligos Therapeutics Inc (ALGS) stock is projected to chart a bullish course in 2040, with an average price target of $5.0086, representing an $-31.20% surge from its current level. The forecast ranges from a conservative $5.2376 to a sky-high $6.0233.
- Our analysts predict Aligos Therapeutics Inc (ALGS) to jump 615.56% by 2045, soaring from $53.29 to an average price of $52.09, potentially reaching $52.44. While $53.29 is the low estimate, the potential upside is significant.
- Aligos Therapeutics Inc (ALGS) stock is expected to climb by 2050, reaching an average of $54.90, a $654.12% jump from its current level. However, a wide range of estimates exists, with high and low targets of $56.37 and $55.01, respectively, highlighting the market's uncertainty.
Aligos Therapeutics Inc Stock (ALGS) Year by Year Forecast
Aligos Therapeutics Inc Stock (ALGS) Price Forecast for 2026
The predicted value for Aligos Therapeutics Inc (ALGS) in 2026 is set at an average of $5.449. Estimates vary from a peak of $7.1262 to a trough of $3.7718, indicating an -25.15% surge from the present price of $7.28.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| April, 2026 | $5.9642 | $6.1924 | $6.2607 | -18.07% |
| May, 2026 | $5.9576 | $5.9718 | $5.86 | -18.16% |
| June, 2026 | $5.8911 | $5.8652 | $5.8835 | -19.08% |
| July, 2026 | $5.5804 | $5.6204 | $5.7369 | -23.35% |
| August, 2026 | $5.3689 | $5.4738 | $5.4883 | -26.25% |
| September, 2026 | $5.1602 | $5.1602 | $5.2697 | -29.12% |
| October, 2026 | $4.1567 | $4.6063 | $4.9249 | -42.90% |
| November, 2026 | $3.7901 | $3.7718 | $3.6243 | -47.94% |
| December, 2026 | $3.7095 | $3.7995 | $3.6436 | -49.05% |
Aligos Therapeutics Inc Stock (ALGS) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Aligos Therapeutics Inc (ALGS) is $2.5748, with a high forecast of $3.9182 and a low forecast of $1.2314. This indicates an -64.63% decrease from the last price of $7.28.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $4.0889 | $3.8812 | $3.6929 | -43.83% |
| February, 2027 | $3.5464 | $3.7164 | $3.9182 | -51.29% |
| March, 2027 | $3.2557 | $3.3157 | $3.3281 | -55.28% |
| April, 2027 | $3.1632 | $3.1774 | $3.1016 | -56.55% |
| May, 2027 | $2.9176 | $2.9176 | $3.015 | -59.92% |
| June, 2027 | $2.692 | $2.697 | $2.8203 | -63.02% |
| July, 2027 | $2.4554 | $2.4653 | $2.5278 | -66.27% |
| August, 2027 | $2.2699 | $2.3187 | $2.3713 | -68.82% |
| September, 2027 | $1.958 | $2.1182 | $2.1657 | -73.10% |
| October, 2027 | $1.7617 | $1.7817 | $1.8293 | -75.80% |
| November, 2027 | $1.5051 | $1.6252 | $1.6394 | -79.33% |
| December, 2027 | $1.1935 | $1.2314 | $1.369 | -83.61% |
Aligos Therapeutics Inc Stock (ALGS) Price Forecast for 2028
In 2028, Aligos Therapeutics Inc (ALGS) is projected to reach an average price of $6.1196, with a high projection of $12.20 and a low estimate of $0.0442. This indicates an -15.94% fall from the last price of $7.28.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.9779 | $1.0079 | $1.0923 | -86.57% |
| February, 2028 | $0.5313 | $0.4555 | $0.7138 | -92.70% |
| March, 2028 | $0.0507 | $0.0607 | $0.3373 | -99.30% |
| April, 2028 | $0.0413 | $0.0442 | $0.0384 | -99.43% |
| May, 2028 | $9.4669 | $8.9452 | $12.20 | +30.04% |
| June, 2028 | $2.0238 | $5.1774 | $8.5487 | -72.20% |
| July, 2028 | $5.0192 | $0.739 | $9.9792 | -31.05% |
| August, 2028 | $3.8406 | $0.2906 | $11.04 | -47.24% |
| September, 2028 | $1.2964 | $0.7112 | $5.0888 | -82.19% |
| October, 2028 | $3.4633 | $3.5715 | $2.4498 | -52.43% |
| November, 2028 | $3.1019 | $1.1485 | $5.4515 | -57.39% |
| December, 2028 | $9.8211 | $1.6229 | $10.53 | +34.91% |
Aligos Therapeutics Inc Stock (ALGS) Price Forecast for 2029
The 2029 price forecast for Aligos Therapeutics Inc Stock (ALGS) is $7.9911 on average, with a high prediction of $15.89 and a low estimate of $0.0877. This represents an +9.77% increase from the previous price of $7.28.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $7.0575 | $0.0877 | $9.9294 | -3.06% |
| February, 2029 | $6.8944 | $8.451 | $6.4193 | -5.30% |
| March, 2029 | $5.0614 | $5.9714 | $6.5879 | -30.48% |
| April, 2029 | $5.8783 | $5.6531 | $5.5083 | -19.25% |
| May, 2029 | $5.1369 | $5.9969 | $5.7335 | -29.44% |
| June, 2029 | $4.4439 | $4.6039 | $3.8487 | -38.96% |
| July, 2029 | $8.0308 | $5.5056 | $6.1508 | +10.31% |
| August, 2029 | $15.89 | $7.971 | $15.15 | +118.26% |
| September, 2029 | $15.72 | $16.00 | $15.85 | +115.88% |
| October, 2029 | $15.85 | $15.88 | $15.89 | +117.65% |
| November, 2029 | $15.47 | $15.55 | $15.32 | +112.53% |
| December, 2029 | $15.71 | $15.50 | $15.52 | +115.78% |
Aligos Therapeutics Inc Stock (ALGS) Price Forecast for 2030
Aligos Therapeutics Inc Stock (ALGS) is expected to reach an average price of $12.29 in 2030, with a high forecast of $15.55 and a low forecast of $9.0189. This signifies an +68.76% surge from the last price of $7.28.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $15.22 | $15.44 | $15.55 | +109.03% |
| February, 2030 | $14.84 | $14.80 | $14.92 | +103.91% |
| March, 2030 | $14.01 | $14.21 | $14.45 | +92.46% |
| April, 2030 | $13.43 | $13.73 | $13.71 | +84.45% |
| May, 2030 | $13.07 | $13.14 | $13.26 | +79.49% |
| June, 2030 | $12.67 | $12.79 | $12.80 | +74.09% |
| July, 2030 | $12.08 | $12.10 | $12.50 | +65.97% |
| August, 2030 | $11.63 | $11.70 | $11.89 | +59.75% |
| September, 2030 | $11.21 | $11.21 | $11.45 | +54.03% |
| October, 2030 | $9.4051 | $9.6951 | $10.90 | +29.19% |
| November, 2030 | $9.432 | $9.3303 | $9.2568 | +29.56% |
| December, 2030 | $8.9289 | $9.0189 | $8.9837 | +22.65% |
0.99%
3.03%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):